DOET(2,5-Dimethoxy-4-Ethylamphetamine), a New Psychotropic Drug
Archives of General Psychiatry January 1, 1971 DOI: 10.1001/archpsyc.1971.01750070052006 via OpenAlex
Summary
AI-generated from the abstractDOET, a new psychotropic agent chemically related to mescaline and amphetamine, was given to normal male subjects in doses from 0.75 to 4 mg. It produced mild euphoria, enhanced self-awareness, and anxiety at higher doses, but no hallucinogenic or psychotomimetic effects occurred at any dose. The enhanced awareness from DOET was not linked to such actions across a five-fold active dose range.
Study at a glance
| Characteristics | Controlled trial Peer reviewed |
|---|---|
| Population | Normal male subjects |
| Intervention | DOET |
| Dose | 0.75 to 4 mg |
| Topics | LSD Mescaline Psilocybin |
| Keywords | Psychotomimetic Hallucinogen Euphoriant Amphetamine |
| Citations | 30 |
| Key finding | DOET produced mild euphoria and enhanced self-awareness without hallucinogenic or psychotomimetic effects at doses up to 4 mg. |
Abstract
DOET (2,5-dimethoxy-4-ethylamphetamine) is a new psychotropic agent which chemically resembles mescaline and amphetamine. It is essentially the ethyl homologue of DOM (2,5-dimethoxy-4-methylamphetamine), a psychotomimetic drug widely used by hippie populations and designated "STP." DOET was administered to normal male subjects in doses ranging from 0.75 to 4 mg and contrasted with effects of a water placebo. In all cases DOET produced subjective effects including a mild euphoria, a feeling of enhanced self-awareness, and a tendency to feel "anxious" at higher doses. Although there was some increase in subjective effects at higher doses, this was not marked. No hallucinogenic or psychotomimetic effects were observed at any dose. Thus, over a five-fold range of pharmacologically active dosage, the "enhanced awareness" produced by DOET was not associated with psychotomimetic or hallucinogenic actions. PSYCHEDELIC drugs embrace a large number of agents of widely different chemical classes but which produce notably similar profound subjective effects.1Nuances of subjective effects which may vary among drugs2have not been well quantified. Shulgin3.4has synthesized a large number of methoxylated amphetamines related to mescaline and amphetamine. One of these, DOM (2, 5-dimethoxy-4-methylamphetamine) (Fig 1), informally designated "STP," was psychotomimetic and hallucinogenic in doses larger than 5 mg, and was about 50 to 100